Alentis Therapeutics AG

AI Quick Summary

Alentis Therapeutics is a clinical-stage biotechnology company with a mission to treat cancer and reverse fibrosis. To this end, we are pioneering first-in-class antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) targeting Claudin-1 (CLDN1) for oncology and multi-organ fibrosis.Since our inception in 2019, we have been the leading biotech company developing anti-Claudin-1 therapies. Claudin-1 is an extraordinary target that plays a key role in many solid tumors and fibrosis and we are committed to unlocking its broad potential and bringing much-needed new medicines to patients.

Organization Metadata

• Organization Name: Alentis Therapeutics AG
• Date: 9/19/2024 9:17:51 AM
• Administrators:
  • Park Basel Area

Organization Description

Alentis Therapeutics is a clinical-stage biotechnology company with a mission to treat cancer and reverse fibrosis. To this end, we are pioneering first-in-class antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) targeting Claudin-1 (CLDN1) for oncology and multi-organ fibrosis.

Since our inception in 2019, we have been the leading biotech company developing anti-Claudin-1 therapies. Claudin-1 is an extraordinary target that plays a key role in many solid tumors and fibrosis and we are committed to unlocking its broad potential and bringing much-needed new medicines to patients.